NO20011403L - Terapi for å forbedre kongestion - Google Patents

Terapi for å forbedre kongestion

Info

Publication number
NO20011403L
NO20011403L NO20011403A NO20011403A NO20011403L NO 20011403 L NO20011403 L NO 20011403L NO 20011403 A NO20011403 A NO 20011403A NO 20011403 A NO20011403 A NO 20011403A NO 20011403 L NO20011403 L NO 20011403L
Authority
NO
Norway
Prior art keywords
therapy
improve congestion
congestion
improve
Prior art date
Application number
NO20011403A
Other languages
English (en)
Other versions
NO20011403D0 (no
Inventor
Paul Leonce Irma De Nijs
Wim Louis Julien Parys
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20011403L publication Critical patent/NO20011403L/no
Publication of NO20011403D0 publication Critical patent/NO20011403D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20011403A 1998-10-16 2001-03-20 Terapi for Õ forbedre kongestion NO20011403D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203454 1998-10-16
PCT/EP1999/007804 WO2000023057A2 (en) 1998-10-16 1999-10-12 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition

Publications (2)

Publication Number Publication Date
NO20011403L true NO20011403L (no) 2001-03-20
NO20011403D0 NO20011403D0 (no) 2001-03-20

Family

ID=8234219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011403A NO20011403D0 (no) 1998-10-16 2001-03-20 Terapi for Õ forbedre kongestion

Country Status (20)

Country Link
EP (1) EP1121131A2 (no)
JP (1) JP2002527469A (no)
KR (1) KR20010072878A (no)
CN (1) CN1367697A (no)
AU (1) AU6472799A (no)
BG (1) BG105302A (no)
BR (1) BR9914419A (no)
CA (1) CA2345767A1 (no)
EE (1) EE200100136A (no)
HK (1) HK1039745A1 (no)
HR (1) HRP20010262A2 (no)
HU (1) HUP0103781A3 (no)
ID (1) ID28441A (no)
IL (1) IL142588A0 (no)
NO (1) NO20011403D0 (no)
PL (1) PL348107A1 (no)
SK (1) SK4592001A3 (no)
TR (1) TR200101082T2 (no)
WO (1) WO2000023057A2 (no)
ZA (1) ZA200103081B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
AU2006201188B2 (en) * 2001-02-05 2007-11-15 Novartis Ag New use of iloperidone
ES2358416T3 (es) 2001-10-30 2011-05-10 Novartis Ag Formulaciones de liberación prolongada de iloperidona y polímero en forma de estrella.
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
WO2005065645A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
JP2008523058A (ja) * 2004-12-10 2008-07-03 アボット・ラボラトリーズ 縮合ビシクロ複素環置換キヌクリジン誘導体
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
CN101668525A (zh) 2007-03-01 2010-03-10 前体生物药物股份公司 谷氨酰胺酰环化酶抑制剂的新用途
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (es) * 2007-07-16 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias.
BR112012019923A2 (pt) 2010-02-09 2016-08-09 Univ Johns Hopkins métodos e composições para melhorar a função cognitiva
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
CN107810002B (zh) 2015-05-22 2021-01-05 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DK0584185T3 (da) * 1991-05-14 2000-02-07 Ernir Snorrason Behandling af træthedssyndrom med cholinesteraseinhibitorer
CA2300148C (en) * 1997-08-11 2009-06-23 University Of South Florida Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
PT1073432E (pt) * 1998-04-14 2007-10-22 Gen Hospital Corp Utilização da d-alanina ou da d-serina para o tratamento da esquizofrenia

Also Published As

Publication number Publication date
CN1367697A (zh) 2002-09-04
TR200101082T2 (tr) 2001-09-21
SK4592001A3 (en) 2001-12-03
ZA200103081B (en) 2002-07-12
NO20011403D0 (no) 2001-03-20
JP2002527469A (ja) 2002-08-27
BR9914419A (pt) 2001-06-26
HUP0103781A2 (hu) 2002-03-28
WO2000023057A3 (en) 2000-07-27
IL142588A0 (en) 2002-03-10
EE200100136A (et) 2002-06-17
PL348107A1 (en) 2002-05-06
CA2345767A1 (en) 2000-04-27
WO2000023057A2 (en) 2000-04-27
AU6472799A (en) 2000-05-08
HRP20010262A2 (en) 2002-06-30
EP1121131A2 (en) 2001-08-08
BG105302A (en) 2001-11-30
HUP0103781A3 (en) 2003-09-29
HK1039745A1 (zh) 2002-05-10
ID28441A (id) 2001-05-24
KR20010072878A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
NO20011403L (no) Terapi for å forbedre kongestion
DE59910140D1 (de) Gleitschalungsfertiger
ID27841A (id) Turunan-turunan biaril terapeutik
ID26974A (id) Ketoenol siklik arilfenil-tersubstitusi
ATE321483T1 (de) Dose
NO20003640D0 (no) Ny doseringsform
DE60038698D1 (de) Hydrogel-gesteuerte dosierungsform
DK1637127T3 (da) Terapeutisk mikroskum
ATE229954T1 (de) Betacarbolinverbindungen
NO992692L (no) Nefadozon doseringsform
NO994626D0 (no) Substituerte benzamider
DE60007530D1 (de) Oral wirksame androgene
ID27346A (id) Peralatan pengenal suara
DE69903000D1 (de) Vorschaltgerät
NO980415L (no) Innretning for å vannrensing
DE69912978D1 (de) Oral anzuwendendes sertralinhaltiges konzentrat
NO20023164L (no) Buekonstruksjon
NO980270L (no) Trekkanordning
FI990432A0 (fi) Kaksiviiraformeri
ATA183598A (de) Tor
NO20006198D0 (no) Fremgangsmåter for å inhibere TEF-3-aktivitet
LV12068A (lv) Kasete megenem
IT1299030B1 (it) Dispositivo per produrre scarpe
ITMI980151A1 (it) Protein-disolfuro isomerasi come agenti terapeutici
SE9802023D0 (sv) New therapeutic use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application